Inhibition of K+-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin

Neuroscience Letters

Volumn 280, Issue 2, 2000, Pages 107-110

  Dooley, David J ^a   Mieske, Cindy A ^a   Borosky, Susan A ^a  

^a PFIZER INC   (United States)

Author keywords

Agatoxin; Conotoxin; Calcium Channels; Gabapentin; Glutamate; Hippocampus; Neocortex; Pregabalin; Rat

Indexed keywords

GABAPENTIN; GLUTAMIC ACID; NEUROTRANSMITTER; OMEGA AGATOXIN; OMEGA CONOTOXIN; POTASSIUM ION; PREGABALIN;

ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN SLICE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFICACY; HIPPOCAMPUS; HYPERALGESIA; NEOCORTEX; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETIC ACIDS; AMINES; ANIMALS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HIPPOCAMPUS; MALE; NEOCORTEX; OMEGA-CONOTOXINS; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; SPIDER VENOMS;

EID: 0033965974     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00769-2     Document Type: Article

References (20)

1. Bryans, J.S. and Wustrow, D.J., 3-Substituted GABA analogs with central nervous system activity: a review. Med. Res. Rev., 19 (1999) 149-177.
2. 2+ channel toxins. Eur. J. Pharmacol., 238 (1993) 383-386.
3. Field, M.J., Gonzalez, M.I. and Singh, L., Gabapentin and related compounds. In C. Bountra and R. Munglani, and W.K. Schmidt (Eds.), Pain: Current Understanding, Emerging Therapies, and Novel Approaches to Drug Discovery, Marcel Dekker, New York, 2000 (in press).
4. 2δ subunit of a calcium channel. J. Biol. Chem., 271 (1996) 5768-5776.
5. Godfraind, T., Miller, R. and Wibo, M., Calcium antagonism and calcium entry blockade. Pharmacol. Rev., 38 (1986) 321-416.
6. Goldlust, A., Su, T.-Z., Welty, D.F., Taylor, C.P. and Oxender, D.L., Effects of the anticonvulsant drug gabapentin on enzymes in the metabolic pathways of glutamate and GABA. Epilepsy Res., 22 (1995) 1-11.
7. Harvey, J., Wedley, S., Findlay, J.D., Sidell, M.R. and Pullar, I.A., ω-Agatoxin IVA identifies a single calcium channel subtype which contributes to the potassium-induced release of acetylcholine, 5-hydroxytryptamine, dopamine, γ-aminobutyric acid and glutamate from rat brain slices. Neuropharmacology., 35 (1996) 385-392.
8. 3H]-gabapentin to a novel site in rat brain: autoradiographic studies. Eur. J. Pharmacol., 244 (1993) 303-309.
9. Hutson, S.M., Berkich, D., Drown, P., Xu, B., Aschner, M. and LaNoue, K.F., Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism, . J. Neurochem., 71 (1998) 863-874.
10. Kimura, M., Yamanishi, Y., Hanada, T., Kagaya, T., Kuwada, M., Watanabe, T., Katayama, K. and Nishizawa, Y., Involvement of P-type calcium channels in high potassium-elicited release of neurotransmitters from rat brain slices. Neuroscience, 66 (1995) 609-615.
11. 2δ subunit. J. Neurosci., 19 (1999) 684-691.
12. Miljanich, G.P. and Ramachandran, J., Antagonists of neuronal calcium channels: structure, function, and therapeutic implications. Annu. Rev. Pharmacol. Toxicol., 35 (1995) 707-734.
13. Scheyer, R.D., Involvement of glutamate in human epileptic activities. Prog. Brain Res., 116 (1998) 359-369.
14. Shimoyama, M., Shimoyama, N. and Hori, Y., Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain, (2000) in press.
15. Stefani, A., Spadoni, F. and Bernardi, G., Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology., 37 (1997) 83-91.
16. 3H]-gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur. J. Pharmacol., 244 (1993) 293-301.
17. Taylor, C.P., Gee, N.S., Su, T.-Z., Kocsis, J., Welty, D., Brown, J.P., Dooley, D.J., Boden, P. and Singh, L., A summary of the mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res., 29 (1997) 233-249.
18. Thomas, R.J., Excitatory amino acids in health and disease. J. Am Geriatr. Soc., 43 (1995) 1279-1289.
19. 2+ channels: role in channel function. Trends Neurosci., 21 (1998) 148-154.
20. Yuen, P.W., Kanter, G.D., Taylor, C.P. and Vartanian, M.G., Enantioselective synthesis of PD 144723: a potent stereospecific anticonvulsant. Bioorg. Med. Chem. Lett., 4 (1994) 823-826.